▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for JD Health International in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $19.00.
The current consensus among 1 investment analysts is to buy stock in JD Health International.
JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products through direct selling and online retail pharmacy network. The company also provides online healthcare services, such as online consultation and prescription renewal, chronic disease management, family doctor, and consumer healthcare services, as well as health management and intelligent healthcare solutions. In addition, its platform allows users to make appointments and pay for services, such as general physical exams, aesthetic medicines, vaccination appointments, dental care services, and genetic tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.